Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist, which complements diet and exercise. It’s known to improve glycemic control in adults with type 2 diabetes, and has recently been proven to support weight loss in individuals with a high BMI.

Tirzepatide works by improving insulin secretion and blood sugar control, and slowing gastric emptying. Its dual-hormone action may help regulate appetite, reduce cravings, and promote a feeling of fullness.

This medication not only helps stabilize blood sugar but also encourages steady weight loss by reducing overall calorie consumption. While noticeable weight changes can occur with minimal lifestyle changes, combining tirzepatide with a healthy diet and exercise can amplify results, making it a powerful tool for long-term health goals.

Individuals typically report little to no side effects. Side effects may include: Nausea, vomiting, diarrhea, stomach discomfort, constipation, dizziness, or tiredness.

Tirzepatide works by targeting two key hormone pathways, GLP-1 and GIP, to address multiple factors affecting weight and metabolic health. It reduces inflammation and oxidative stress, which can contribute to tissue damage and metabolic dysfunction.

By interacting with neurotransmitters, tirzepatide helps suppress appetite and enhances feelings of fullness, leading to reduced food intake. It also slows digestion, delaying the emptying of the stomach and promoting more consistent energy levels throughout the day.

Additionally, tirzepatide improves blood sugar regulation by increasing insulin secretion and lowering glucagon levels, making it effective for managing both weight and glycemic control.

Tirzepatide differs from semaglutide in that it targets two hormones, GLP-1 and GIP, while semaglutide focuses solely on GLP-1. This dual-action mechanism allows tirzepatide to provide a more comprehensive metabolic effect, which may result in less appetite, improved blood sugar control, and enhanced overall metabolism. Many patients report experiencing fewer side effects with tirzepatide compared to semaglutide, making it a more comfortable option for some.

In terms of pricing, Semaglutide is priced at $299/month, while Tirzepatide is $399/month. Both medications offer effective support for weight loss and metabolic health, and your provider can help determine the best option for your needs.

Through iThriveMD, Revive clients can purchase a membership. The tirzepatide membership is $399 billed monthly and includes:

– Complimentary consultation

– Weekly injections (4 total)

– Monthly check-in with a provider

– Lab analysis

– Personalized weight loss plan

In addition, individuals may anticipate the following costs:

‍Initial Blood Work ($36 – $185)
– Comprehensive lab panel to assess hormone levels, immune function, and metabolism to inform treatment plans. 
– Will be repeated every 6 months for monitoring.